Christina Elisabeth Herder

Directeur/Membre du Conseil chez ELICERA THERAPEUTICS AB

Profil

Dr. Christina Elisabeth Herder is an Independent Director at Elicera Therapeutics AB, a Chief Executive Officer & Director at Idogen AB, a Deputy Director at Glycovisc BioTech AB and a Director at Medivir Personal AB. She is on the Board of Directors at Elicera Therapeutics AB, Idogen AB and Herder Consulting AB. Dr. Herder was previously employed as an Independent Director by PCI Biotech Holding ASA, a Chief Executive Officer by Modus Therapeutics AB, a Vice President-Licensing & Portfolio Management by Biovitrum AB, an Executive VP-Strategic Business Development by Medivir AB, a Chief Executive Officer by Modus Therapeutics Holding AB, and a Director-Corporate Development by Swedish Orphan Biovitrum AB. She also served on the board at Akinion Pharmaceuticals AB and Ziccum AB. She received her MBA from the University of Stockholm and a doctorate degree from Royal Institute of Technology.

Postes actifs de Christina Elisabeth Herder

Sociétés	Poste	Début
ELICERA THERAPEUTICS AB	Directeur/Membre du Conseil	01/01/2020
Idogen AB	Directeur Général	01/09/2022
Herder Consulting AB	Directeur/Membre du Conseil	-
Glycovisc BioTech AB	Corporate Officer/Principal	-
Medivir Personal AB	Corporate Officer/Principal	-

Anciens postes connus de Christina Elisabeth Herder

Sociétés	Poste	Fin
PCI BIOTECH HOLDING ASA	Directeur/Membre du Conseil	25/05/2023
MEDIVIR AB	Corporate Officer/Principal	01/12/2021
Modus Therapeutics AB	Directeur Général	25/04/2017
Akinion Pharmaceuticals AB	Directeur/Membre du Conseil	01/01/2014
░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-